Skip to main content

Table 1 Baseline characteristics, vascular risk factors, stroke etiology, stroke severity, in-hospital complications and 90-day outcomes in humans

From: Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models

 

Stroke

Controls

P

 

(n = 51)

(n = 17)

 

Baseline, demographic data and risk factors

   

Men, n (%)

24 (47)

8 (47)

1

Age, mean (SD)

73.5 (10.3)

70.4 (15)

0.353

Symptoms onset to first blood sample, h; mean (SD)

4.8 (3.3)

5 (3.3)

0.795

Symptoms Onset to second blood sample, h; mean (SD)

71.2 (4.9)

73.5 (4.1)

0.394

Systolic blood pressure on admission, mean (SD)

154.3 (19)

149.2 (32.3)

0.467

Blood glucose, mmol/L; median (IQR)

123 (38)

133 (106)

0.100

Hypertension, n (%)

34 (66.7)

12 (70.6)

0.765

Diabetes Mellitus, n (%)

10 (19.6)

6 (35.3)

0.187

Hyperlipidemia, n (%)

17 (33.3)

7 (41.2)

0.558

Atrial Fibrillation, n (%)

22 (43.1)

0 (0)

0.001

Current smoking, n (%)

13 (25.5)

5 (29.4)

0.751

Alcohol abuse, n (%)

2 (3.9)

2 (11.8)

1

Coronary heart disease, n (%)

8 (15.7)

2 (11.8)

1

Peripheral arterial disease, n (%)

1 (2)

2 (5.9)

0.440

Disease severity

   

NIHSS score on admission, mean (SD)

11.3 (6)

-

-

APACHE II score on admission, mean (SD)

7.4 (2.6)

7 (2.5)

0.555

90-days outcome

   

mRS 0-2, n (%)

27 (53)

10 (58.8)

0.723

Barthel index ≥ 90, n (%)

22 (43.1)

6 (35.3)

0.569

Mortality, n (%)

7 (13.7)

0 (0)

0.175

Brain infarction size, ml; median (IQR)

27.8 (78)

-

 

First and second tertile, ml, range

3 - 40

-

 

Third tertile, ml, range

50 - 405

-

 
  1. NIHSS indicates National Institutes of Health Stroke Scale; IQR, interquartile range; mRS, modified Rankin Scale.